Art. 18 Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006…

Safety and efficacy of medicinal products

In forcesince 17 May 2006
1.

Where the application for a compulsory licence concerns a medicinal product, the applicant may avail himself of:

(a)

the scientific opinion procedure as provided for under Article 58 of Regulation (EC) No 726/2004, or

(b)

any similar procedures under national law, such as scientific opinions or export certificates intended exclusively for markets outside the Community.

2.

If a request for any of the above procedures concerns a product which is a generic of a reference medicinal product which is or has been authorised under Article 6 of Directive 2001/83/EC, the protection periods set out in Article 14(11) of Regulation (EC) No 726/2004 and in Articles 10(1) and 10(5) of Directive 2001/83/EC shall not apply.